E. Coli outbreak persists and the CDC has yet to place blame
The outbreak of the dangerous bacteria is over in Canada, but new cases emerged in the US just last week. The number of cases has surpassed 40 and the CDC is waiting to blame a specific plant, though leafy greens are the prime suspect. The CDC and FDA have weathered harsh criticism for their handling…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Get featured
Want to get featured in MarketScale Healthcare?
Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.
The outbreak of the dangerous bacteria is over in Canada, but new cases emerged in the US just last week. The number of cases has surpassed 40 and the CDC is waiting to blame a specific plant, though leafy greens are the prime suspect. The CDC and FDA have weathered harsh criticism for their handling of the outbreak. Critics cite slow response time and an inability to ensure that recalls are initiated properly. Contamination is hard to pin down and E. coli can’t be washed from leaves, but it seems best to avoid romaine lettuce for now.
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
